Charles River Laboratories International, Inc.:戦略・SWOT・企業財務分析

◆英語タイトル:Charles River Laboratories International, Inc. - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA8015212
◆発行会社(調査会社):MarketLine
◆発行日:2017年9月30日
◆ページ数:58
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Charles River Laboratories International, Inc. – Strategy, SWOT and Corporate Finance Report
Summary

Charles River Laboratories International, Inc. – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Charles River Laboratories International (CRL or ‘the company’) is a full service, early-stage contract research organization. The company operates in the US, Europe, Japan, Canada and other regions of the world. It is headquartered in Wilmington, Massachusetts, and employed about 7,900 people as on December 27, 2014.

Scope

- Detailed information on Charles River Laboratories International, Inc. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Charles River Laboratories International, Inc. in the form of a SWOT analysis
- An in-depth view of the business model of Charles River Laboratories International, Inc. including a breakdown and examination of key business segments
- Intelligence on Charles River Laboratories International, Inc.’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Charles River Laboratories International, Inc., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Charles River Laboratories International, Inc. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Charles River Laboratories International, Inc. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Charles River Laboratories International, Inc.’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Charles River Laboratories International, Inc.: Company Overview
Charles River Laboratories International, Inc.: Overview and Key Facts
Charles River Laboratories International, Inc.: Overview
Charles River Laboratories International, Inc.: Key Facts
Charles River Laboratories International, Inc.: Key Employees
Charles River Laboratories International, Inc.: Key Employee Biographies
Charles River Laboratories International, Inc.: Major Products and Services
Charles River Laboratories International, Inc.: Company History
Charles River Laboratories International, Inc.: Management Statement
Charles River Laboratories International, Inc.: Locations and Subsidiaries
Charles River Laboratories International, Inc.: Key Competitors
Charles River Laboratories International, Inc.: Company Analysis
Charles River Laboratories International, Inc.: Business Description
Charles River Laboratories International, Inc.: SWOT Analysis
Charles River Laboratories International, Inc.: SWOT Overview
Charles River Laboratories International, Inc.: Strengths
Charles River Laboratories International, Inc.: Weaknesses
Charles River Laboratories International, Inc.: Opportunities
Charles River Laboratories International, Inc.: Threats
Charles River Laboratories International, Inc.: Corporate Financial Deals Activity
Charles River Laboratories International, Inc.: Financial Deals Overview
Charles River Laboratories International, Inc.: Targets and Partners
Charles River Laboratories International, Inc.: Top Deals 2013 – 2017YTD*
Charles River Laboratories International, Inc.: Advisors
Charles River Laboratories International, Inc.: Top Legal Advisors
Charles River Laboratories International, Inc.: Top Financial Advisors
Charles River Laboratories International, Inc.: Mergers and Acquisitions
Charles River Laboratories International, Inc.: Corporate Venturing
Charles River Laboratories International, Inc.: Partnership
Charles River Laboratories International, Inc.: Divestments
Charles River Laboratories International, Inc.: Recent Developments
Charles River Laboratories International, Inc.: News and Events Summary
Charles River Laboratories International, Inc.: Business Expansion
Charles River Laboratories International, Inc.: Contracts
Charles River Laboratories International, Inc.: Corporate Governance
Charles River Laboratories International, Inc.: Financial Performance
Charles River Laboratories International, Inc.: Market Developments
Charles River Laboratories International, Inc.: Red Flags/DistressSignals
Charles River Laboratories International, Inc.: Research & Development
Charles River Laboratories International, Inc.: Strategy and Operations
Appendix
Contact Us
Methodology
Definitions
About MarketLine

List of Tables
Table 1: Charles River Laboratories International, Inc.: Key Facts
Table 2: Charles River Laboratories International, Inc.: Key Employees
Table 3: Charles River Laboratories International, Inc.: Locations and Subsidiaries
Table 4: Charles River Laboratories International, Inc.: Key Competitors
Table 5: Charles River Laboratories International, Inc.: Deal Activity by Deal Type - Volume (TTM*)
Table 6: Charles River Laboratories International, Inc.: M&A Activity by Geography (TTM*)
Table 7: Charles River Laboratories International, Inc.: Deal Activity by Deal Type - Volume (2013 - YTD*2017)
Table 8: Charles River Laboratories International, Inc.: M&A Average Deal Size - Value (US$m)
Table 9: Charles River Laboratories International, Inc.: Targets and Partners
Table 10: Charles River Laboratories International, Inc.: Top Deals 2013 - 2017YTD*
Table 11: Charles River Laboratories International, Inc.: Legal Advisor Ranking by Value (US$m)
Table 12: Charles River Laboratories International, Inc.: Financial Advisor Ranking by Value (US$m)
Table 13: Charles River Laboratories International, Inc.: M&A Volume and Value Trend (2013 - YTD*2017)
Table 14: Charles River Laboratories International, Inc.: M&A Activity by Geography (2013 - YTD*2017)
Table 15: Charles River Laboratories International, Inc.: Corporate Venturing Volume and Value Trend (2013 - YTD*2017)
Table 16: Charles River Laboratories International, Inc.: Corporate Venturing by Geography (2013 - YTD*2017)
Table 17: Charles River Laboratories International, Inc.: Partnership Volume and Value Trend (2013 - YTD*2017)
Table 18: Charles River Laboratories International, Inc.: Partnership Trend by Deal Type (2013 - YTD*2017)
Table 19: Charles River Laboratories International, Inc.: Divestments Volume and Value Trend (2013 - YTD*2017)
Table 20: Charles River Laboratories International, Inc.: News and Events Summary
Table 21: Charles River Laboratories International, Inc.: Business Expansion
Table 22: Charles River Laboratories International, Inc.: Contracts
Table 23: Charles River Laboratories International, Inc.: Corporate Governance
Table 24: Charles River Laboratories International, Inc.: Financial Performance
Table 25: Charles River Laboratories International, Inc.: Market Developments
Table 26: Charles River Laboratories International, Inc.: Red Flags/DistressSignals
Table 27: Charles River Laboratories International, Inc.: Research & Development
Table 28: Charles River Laboratories International, Inc.: Strategy and Operations

★海外企業調査レポート[Charles River Laboratories International, Inc.:戦略・SWOT・企業財務分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Suda Ltd (SUD)-製薬・医療分野:企業M&A・提携分析
    Summary Suda Ltd (Suda) is a drug delivery company that offers oro-mucosal administration solutions. The company’s products include artimist, zolpimist, SUD-001, SUD-002, SUD-003, SUD-004 and SUD-005. Its artimist is a sub-lingual spray for the treatment of p. falciparum severe paediatric malaria. S …
  • Lixte Biotechnology Holdings Inc (LIXT):製薬・医療:M&Aディール及び事業提携情報
    Summary Lixte Biotechnology Holdings Inc (Lixte) is a clinical stage pharmaceutical company, which focuses on the discovery of novel drugs for the treatment of cancer and non-malignant diseases. It develops comprises two classes of drugs, namely, protein phosphatase inhibitors (PTase-i) designated a …
  • OraSolv AB (OS):企業の財務・戦略的SWOT分析
    OraSolv AB (OS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Hong Leong Asia Ltd (H22):企業の財務・戦略的SWOT分析
    Hong Leong Asia Ltd (H22) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Rio Grande Electric Cooperative, Inc.:企業の戦略的SWOT分析
    Rio Grande Electric Cooperative, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and maj …
  • Litani River Authority:企業の戦略的SWOT分析
    Litani River Authority - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • SJVN Ltd (SJVN)-エネルギー分野:企業M&A・提携分析
    Summary SJVN Limited (SJVN), formerly Satluj Jal Vidyut Nigam Limited-SJVNL, generates and sells hydroelectric power in India. It was formed as a joint venture between the Government of India (GOI) and the Government of Himachal Pradesh (GOHP). The company also focuses on the designing, planning, de …
  • EnBW Energie Baden-Wurttemberg AG (EBK):石油・ガス:M&Aディール及び事業提携情報
    Summary EnBW Energie Baden-Wurttemberg AG (EnBW) is an integrated energy company. Through its subsidiaries, the company generates, procures, transmits, and supplies electricity; and produces, transports and supplies gas. It produces electricity in coal, gas, pumped storage, and nuclear power plants. …
  • Mentor Graphics Corporation:企業の戦略・SWOT・財務情報
    Mentor Graphics Corporation - Strategy, SWOT and Corporate Finance Report Summary Mentor Graphics Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • SerComm Corp (5388):企業の財務・戦略的SWOT分析
    SerComm Corp (5388) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • NanoString Technologies Inc (NSTG):医療機器:M&Aディール及び事業提携情報
    Summary NanoString Technologies Inc (NanoString) is a developer of life science tools for translational research and molecular diagnostics. The company's products include sprint profiler, Dx analysis system with flex, nCounter MAX analysis system, protein assays, solid tumor assays, gene fusion pane …
  • Mylan N.V.:企業の戦略・SWOT・財務情報
    Mylan N.V. - Strategy, SWOT and Corporate Finance Report Summary Mylan N.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Allergan Plc (AGN):医療機器:M&Aディール及び事業提携情報
    Summary Allergan Plc (Allergan) is a specialty pharmaceutical company that develops and sells branded pharmaceuticals, biosimilar and over-the-counter (OTC) pharmaceutical products. It offers products in the areas of eye care, medical aesthetics, dermatology, central nervous system, gastroenterology …
  • Royal DSM NV (DSM):電力:M&Aディール及び事業提携情報
    Summary Royal DSM NV (DSM) is a science-based company with focus on materials, health and nutrition. It produces vitamins, carotenoids, nutritional lipids and other ingredients; specialty plastics; and fiber and resins solutions. DSM develops materials for medical devices and clean energy from crop …
  • The Progressive Corporation:企業の戦略・SWOT・財務情報
    The Progressive Corporation - Strategy, SWOT and Corporate Finance Report Summary The Progressive Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Precipio Inc (TBIO):医療機器:M&Aディール及び事業提携情報
    Summary Precipio Inc (Precipio), formerly Transgenomic Inc, is a developer and provider of diagnostic tools and services. The company advances personalized medicine for the detection and treatment of cancer, and inherited diseases through its molecular technologies and clinical and research services …
  • Biowa Inc-製薬・医療分野:企業M&A・提携分析
    Summary Biowa Inc (BioWa), a subsidiary of Kyowa Hakko Kirin Co Ltd (KHK), is a science and technology company that provides out licensing of therapeutic antibody technologies of KHK. The company also developes fucose free monoclonal antibodies that increase cellular cytotoxicity. Its technology inc …
  • AzurRx BioPharma Inc (AZRX):企業の財務・戦略的SWOT分析
    AzurRx BioPharma Inc (AZRX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Kyowa Hakko Kirin Co Ltd (4151):企業の財務・戦略的SWOT分析
    Kyowa Hakko Kirin Co Ltd (4151) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Lario Oil & Gas Company:石油・ガス:M&Aディール及び事業提携情報
    Summary Lario Oil & Gas Company (Lario Oil & Gas) is an oil and gas exploration and production company that explores and produces oil and gas properties. The company offers services such as discovering reserves organically from geologic thesis, drill-bit, field delineation, and land acquisition and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆